CD43 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD43 monoclonal antibodies for advanced research in immunology and cell biology. CD43 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD43, also known as leukosialin, is a sialomucin expressed on the surface of leukocytes and plays a critical role in cell adhesion, signaling, and immune response regulation. Understanding CD43's function in modulating interactions between immune cells is essential for investigating various pathological conditions, including autoimmune diseases and cancer. CD43 expression patterns can serve as important markers for monitoring disease progression and treatment effectiveness. Studying CD43's role in cellular communication provides insights into immune system development and function. Research focusing on CD43 continues to reveal new aspects of immune cell behavior and regulation. Santa Cruz Biotechnology monoclonal antibodies targeting CD43 enable researchers worldwide to advance our understanding of immune system function and disease mechanisms.